Original article

The cost-effectiveness of losartan in type 2 diabetics with nephropathy in Switzerland - an analysis of the RENAAL study

MS Sandoz, GW Keusch

DOI: https://doi.org/10.4414/smw.2004.10492
Publication Date: 07.08.2004
Swiss Med Wkly. 2004;134(31-32):440-447

This text is only available as PDF .

Verpassen Sie keinen Artikel!

close